Share Search
Visit the Share Search
Immupharma Accounts Summary
| Date of Accounts | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
| Revenue | n/a | 0.12 | 0.13 | 0.08 | 0.08 |
| Operating Profit / Loss | -3.03 | -6.59 | -5.59 | -6.28 | -8.08 |
| Net Interest | -1.43 | -2.35 | -1.66 | -0.46 | 0.13 |
| Pre Tax Profit | -4.46 | -8.94 | -7.25 | -6.74 | -7.96 |
| Post Tax Profit | -3.81 | -8.17 | -6.86 | -6.12 | -7.21 |
| Profit for the Period | -3.81 | -8.17 | -6.86 | -6.12 | -7.21 |
| Equity Holders of Parent Company | -3.81 | -8.17 | -6.86 | -6.12 | -7.21 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -1.26p | -3.25p | 3.43p | -3.99p | -5.19p |
| Earnings per Share (Diluted) | -1.26p | -3.25p | 3.43p | -3.99p | -5.19p |
| Earnings per Share (Adjusted) | -1.26p | -3.25p | 3.43p | -3.99p | -5.19p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -1.26p | -3.25p | 3.43p | -3.99p | -5.19p |
| Earnings per Share (Diluted) | -1.26p | -3.25p | 3.43p | -3.99p | -5.19p |
| Earnings per Share (Adjusted) | -1.26p | -3.25p | 3.43p | -3.99p | -5.19p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
| Non-Current Assets | |||||
| Intangible Assets | 0.47 | 0.48 | 0.48 | 0.48 | 0.48 |
| Property, Plant and Equipment | 0.39 | 0.35 | 0.41 | 0.21 | 0.16 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | 0.69 | 1.42 | 2.59 | 1.53 | 2.00 |
| Other Non-Current Assets | 0.08 | 0.41 | n/a | n/a | n/a |
| Total Non-Current Assets | 1.64 | 2.65 | 3.49 | 2.22 | 2.65 |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | 0.72 | 0.43 | 0.16 | 0.15 | 0.33 |
| Cash at Bank and in Hand | 0.67 | 1.65 | 5.86 | 1.36 | 4.91 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 0.95 | 1.27 | 1.40 | 2.06 | 0.77 |
| Total Current Assets | 2.34 | 3.35 | 7.42 | 3.58 | 6.01 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 3.97 | 6.00 | 10.92 | 5.80 | 8.66 |
| Current Liabilities | |||||
| Borrowings | 0.00 | 0.00 | 0.01 | 0.03 | 0.10 |
| Other Current Liabilities | 1.45 | 1.58 | 1.25 | 0.51 | 0.91 |
| Total Current Liabilities | 1.45 | 1.58 | 1.26 | 0.53 | 1.01 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | 0.02 |
| Provisions | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Liabilities | n/a | n/a | n/a | n/a | 0.02 |
| Net Assets | 2.52 | 4.41 | 9.65 | 5.27 | 7.62 |
| Capital and Reserves | |||||
| Share Capital | 28.98 | 28.50 | 25.02 | 16.74 | 13.95 |
| Share Premium Account | 28.79 | 27.24 | 27.24 | 27.19 | 27.32 |
| Other Reserves | 5.87 | 5.26 | 3.36 | 1.54 | -0.89 |
| Retained Earnings | -61.12 | -56.58 | -45.97 | -40.19 | -32.76 |
| Shareholders Funds | 2.52 | 4.41 | 9.65 | 5.27 | 7.62 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 2.52 | 4.41 | 9.65 | 5.27 | 7.62 |
| 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 | |
| Operating Margin | n/a% | -5,565.66% | -4,300.00% | -7,850.00% | -10,100.00% |
| Return on Capital Employed | -147.78% | -167.32% | -60.89% | -130.37% | -111.43% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | 3.90 | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 0.61p | 1.18p | 2.75p | 1.44p | 2.14p |